Terry Douglass, Ph.D.
Terry Douglass is the Chairman of the Board of Directors and Chief Executive Officer of ProNova Solutions, LLC. He is also the Chairman of the Provision Center for Proton Therapy, President of Provision Healthcare, LLC and Provision Trust, Inc. and Chairman of the Board of Provision Foundation.
Dr. Douglass served as the Chairman of the Board of CTI Molecular Imaging, Inc., a public company that specialized in the development, production and distribution of products and services for the medical diagnostic imaging market from 1983 to 2005 when it was acquired by Siemens at a market capitalization of $1 billion. He also served as President and CEO of CTI Molecular Imaging from its formation in 1983 until 2003. During this tenure, Dr. Douglass played an integral role in the development and commercialization of positron emission technology (PET) and its development globally, including PET cyclotron technology that now plays a significant role in proton therapy. He was also instrumental in the development of Medicare reimbursement for PET services. From 1968 to 1983, Dr. Douglass was employed at EG&G Ortec, where he served as President during the last three years of service. Dr. Douglass is currently leading the development of the world-class comprehensive cancer care program in the Provision Health Alliance at Dowell Springs.
Dr. Douglass has served or is serving on the following boards: Provision Foundation, LLC, Provision Healthcare, LLC, East Tennessee Diagnostic Center, LLC, Provision Imaging, LLC, Provision Health Partners, LLC, Provision Properties, LLC, Provision Trust, Inc., Provision Radiation Therapy, LLC, CTI Molecular Imaging, Inc., Cyclotron Systems Inc., PETNet Pharmaceutical Services, Inc., Computational Systems, Inc., YMCA, Knoxville Chamber of Commerce, Hope Resource Center, Young Life, and the UTMedical Center Biomedical Imaging Foundation.
Dr. Douglass graduated with B.S., M.S., and Ph.D. degrees in Electrical Engineering from the University of Tennessee.